All Articles
December 6, 2018

GDPR, AI and Machine Learning in the Age of Data Privacy

As of May 2018, the implementation of the General Data Protection Regulation (GDPR) allows European consumers more “ownership” of their data and the ability to remove that data from marketing systems. This POV from Intouch innovation manager Andrew Grojean will answer these questions and provide recommendations for marketers leveraging AI in the new age of data privacy and security.

November 27, 2018

Copay Accumulator Programs: Cost Shifts and Unintended Consequences

Copay accumulator programs have been a topic of great interest to a number of groups, including managed care organizations, biopharma manufacturers, and patients over the past year. There is no industry standard name for copay accumulators; e.g., UnitedHealthcare and Express Scripts use the terms “Coupon Adjustment: Benefit Plan Protection program”

November 14, 2018

US Government Reasserts Commitment to Ensuring Accessible Websites

The Department of Justice reaffirmed its longstanding policy that Title III of the Americans with Disabilities Act (ADA) applies to websites, though once again, it declined to issue specific regulations on what websites need to do to comply with the law. In this POV from our user experience expert, Amy Toft, we explain the importance of accessibility, how adherence to Title III affects websites, and how making content accessible to all users affects pharma.

October 31, 2018

FDA Guidance on Sharing Quantitative Data in DTC Promotion

On October 16, 2018, the Food & Drug Administration (FDA) released a new draft guidance titled Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements. In this POV from Intouch’s external regulatory expert Dale Cooke, we provide an overview of the guidance and offer recommendations for ensuring consumers and healthcare professionals understand promotional communications.

Load More Posts